Trelegy Ellipta Powder For Inhalation is a once-daily inhaler combining fluticasone furoate, umeclidinium, and vilanterol. It helps adults manage chronic obstructive pulmonary disease (COPD) and asthma effectively. Approved by the U.S. FDA, it offers the convenience of triple therapy in a single inhaler. Learn more about its medical use at Mayo Clinic and Drugs.com.

Key Benefits & Uses

Trelegy Ellipta improves lung function and reduces flare-ups. Its combination of an inhaled corticosteroid (fluticasone furoate), a long-acting muscarinic antagonist (umeclidinium), and a long-acting beta-agonist (vilanterol) provides comprehensive respiratory management. Since it is once-daily, patients find it easier to follow their treatment plan. However, it is not suitable for sudden asthma attacks. For safety guidelines, visit the WHO.

How to Use

1. Open the inhaler cover.

2. Exhale fully, place the mouthpiece between your lips, and inhale steadily.

3. Hold your breath for 3–4 seconds, then exhale slowly.

4. Close the inhaler cover.

5. Rinse your mouth with water without swallowing to reduce oral thrush risk.

For detailed instructions, check Drugs.com or Mayo Clinic.

Important Safety Information

Trelegy Ellipta is not for children under 18. Do not use it for sudden breathing problems; always have a rescue inhaler ready. Serious side effects may include pneumonia, high blood pressure, or eye issues like glaucoma. Regular eye exams are recommended. More safety details are available on FDA and WebMD.

Common Side Effects

Patients may experience:

• Upper respiratory infections

• Headache or back pain

• Sore throat or hoarseness

• Mouth and throat discomfort

• Nausea, vomiting, diarrhea

• Painful urination or taste disturbances

• Cough, sinus inflammation, runny nose, flu-like symptoms

Learn more at Healthline and PubMed.

Why Choose Trelegy Ellipta

Trelegy Ellipta simplifies COPD and asthma management by combining three effective medications in one inhaler. Its once-daily regimen boosts adherence, while clinical studies show improved lung function and fewer flare-ups. Trusted medical resources like WHO and Mayo Clinic provide additional insights.